METHYLPREDNISOLONE , PREDNISOLONE , FLUDROCORTISONE , HYDROCORTISONE clinical trials

A 12-Week, Phase 2 Open-Label, Sequential Dose Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 Treatment in Participants with Congenital Adrenal Hyperplasia

This study is looking at a new treatment called CRN04894 for people with Congenital Adrenal Hyperplasia (CAH). It will check if the treatment is safe, how well it works, and how the body handles it. This is an early-stage study.